4//SEC Filing
ACURA PHARMACEUTICALS, INC 4
Accession 0001209191-14-012427
$ACURCIK 0000786947operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:54 PM ET
Size
12.4 KB
Accession
0001209191-14-012427
Insider Transaction Report
Form 4
GALEN EMPLOYEE FUND III LP
10% Owner
Transactions
- Sale
Common Stock
2014-02-18$1.95/sh−2,200$4,290→ 11,526,398 total(indirect: See FN)
Galen Management, LLC
10% Owner
Transactions
- Sale
Common Stock
2014-02-18$1.95/sh−2,200$4,290→ 11,526,398 total(indirect: See FN)
CLAUDIUS LLC
10% Owner
Transactions
- Sale
Common Stock
2014-02-18$1.95/sh−2,200$4,290→ 11,526,398 total(indirect: See FN)
GALEN PARTNERS INTERNATIONAL III L P
10% Owner
Transactions
- Sale
Common Stock
2014-02-18$1.95/sh−2,200$4,290→ 11,526,398 total(indirect: See FN)
GALEN PARTNERS III L P
10% Owner
Transactions
- Sale
Common Stock
2014-02-18$1.95/sh−2,200$4,290→ 11,526,398 total(indirect: See FN)
Footnotes (2)
- [F1]The shares were sold as follows: 2,010 by Galen Partners III, L.P. ("Galen III"), 182 by Galen Partners International III, L.P. ("Galen International") and 8 by Galen Employee Fund III, L.P. ("Employee Fund").
- [F2]The shares are held as follows: 10,533,068 by Galen III, 949,942 by Galen International and 43,388 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000786947
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:54 PM ET
- Size
- 12.4 KB